Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy

NCT03935802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 161

Last updated 2019-05-02

No results posted yet for this study

Summary

The aim of this study was to investigate the systemic effect of radiotherapy on patients with primary non-metastatic breast cancer using CETC and to analyze possible changes in CETC quantity under adjuvant radiotherapy.

Conditions

  • Breast Cancer Female

Interventions

RADIATION

radiation

Sponsors & Collaborators

  • University of Jena

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-01
Primary Completion
2012-09-01
Completion
2018-09-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03935802 on ClinicalTrials.gov